Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Medicina Clinica
|
February 12, 2013
[Acquired haemophilia associated to myasthenia gravis]
Luis Miguel Cano, Helena Quesada, Jessica García-Alhama, et al.
Foot & Ankle Specialist
|
October 15, 2009
Charcot-Marie-tooth disease
Carlos Casasnovas, Luis Miguel Cano, Antonia Albertí, et al.
Healthcare (Basel, Switzerland)
|
December 24, 2021
How Relevant Is the Place Where First-Year College Students Live in Relation to the Increase in Body Mass Index?
Antonio Viñuela, Juan José Criado-Álvarez, Javier Aceituno-Gómez, et al.
The Journal of Headache and Pain
|
June 2, 2023
Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients
Albert Muñoz-Vendrell, Sergio Campoy, Edoardo Caronna, et al.
The Journal of Headache and Pain
|
November 29, 2025
Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response
Albert Muñoz-Vendrell, Sergio Campoy-Díaz, Paloma Valín-Villanueva, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Medicina Clinica
|
February 12, 2013
[Acquired haemophilia associated to myasthenia gravis]
Luis Miguel Cano, Helena Quesada, Jessica García-Alhama, et al.
Foot & Ankle Specialist
|
October 15, 2009
Charcot-Marie-tooth disease
Carlos Casasnovas, Luis Miguel Cano, Antonia Albertí, et al.
Healthcare (Basel, Switzerland)
|
December 24, 2021
How Relevant Is the Place Where First-Year College Students Live in Relation to the Increase in Body Mass Index?
Antonio Viñuela, Juan José Criado-Álvarez, Javier Aceituno-Gómez, et al.
The Journal of Headache and Pain
|
June 2, 2023
Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients
Albert Muñoz-Vendrell, Sergio Campoy, Edoardo Caronna, et al.
The Journal of Headache and Pain
|
November 29, 2025
Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response
Albert Muñoz-Vendrell, Sergio Campoy-Díaz, Paloma Valín-Villanueva, et al.
Page
of 1